Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 28 June 2011, 15:30 HKT/SGT
Share:
    

Source: Hai Kang Life Corporation Limited
Hai Kang Life's EFADchip Technology Featured in Science Magazine

HONG KONG, June 28, 2011 - (ACN Newswire) - Hai Kang Life Corporation Limited ("Hai Kang Life"), a Hong Kong-based biotechnology company founded by professor Albert Cheung-Hoi Yu, has just received significant worldwide attention by being featured in Science magazine, the leading global scientific journal.

The Friday (June 24) issue of Science contained a full page 'News Focus on Biotechnology' article on a revolutionary new lab-on-a-chip technology that is poised to change the current clinical diagnostic paradigm, and put Hong Kong firmly on the international biotech map.

The EFADchip system developed by Hai Kang Life utilizes its propertiary patented technology to detect the presence of a pathogens genetic material in a fraction of the time and with a higher precision than existing tests. This Electric Field Assisted Diagnostic (EFAD) method is also inexpensive, allowing whole at-risk populations to be screened. For example, anyone displaying flu-like symptoms can be tested for the presence of different viruses including H1N1 or SARS. Such screening would allow for accurate disease diagnosis and thus appropriate treatment could be given to patient immediately.

In addition to infectious disease diagnosis, EFADchip can also be used for cancer detection, genetic disease testing, disease surveillance and control, as well as for non-clinical applciations such as veterinary diagnostics, environmental monitoring, testing food for microbial or GMO contamination.

The new EFADchip system comprises of chip and chip-reader ("bio-reader") that can easily be deployed to rural communities where lab facilities are unavailable. In fact, they are so small they can be installed on the office desk top of any doctor. Timely deployment of these units to disease outbreak areas could prevent the development of a global pandemic. According to Zhengping Zhuang, a clinical pathologist at the U.S. National Institutes of Health, who is not connected to Hai Kang Life, the EFADchip and the bio-reader is a unique system and it gets a readout much faster than with other technologies."

Bernard Roizman, a virologist at the University of Chicago in Illinois also comments that the EFADchip system is small in size and effectively it is a lab on a chip on wheels.


Contact:
media@haikanglife.com 


Topic: Research and development
Source: Hai Kang Life Corporation Limited

Sectors: Science & Research, Daily News, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2023 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
BLUETTI's AC200P Remains a Popular Choice for Mobile Power Needs  
June 2, 2023 22:00 HKT/SGT
Vivid Sydney 2023 Kicks Off With Biggest Opening Weekend on Record  
June 2, 2023 21:00 HKT/SGT
Fonepay and LankaPay Sign MOU for Cross-Border Interoperable Payment System  
June 2, 2023 21:00 HKT/SGT
Value Partners to Introduce Strategic Investment from GF Securities to Boost Business Development and Facilitate Long-term Growth  
June 2, 2023 16:25 HKT/SGT
JCB and Joint Stock Commercial Bank for Investment and Development of Vietnam launch the BIDV JCB Ultimate Credit Card in Vietnam  
Friday, June 2, 2023 3:00:00 PM
From Hype to Reality: AI's Role in Augmenting Digital Transformation  
June 2, 2023 14:10 HKT/SGT
Eisai to Present Latest Data on Lemborexant at the 37th Annual Sleep 2023 Meeting  
Friday, June 2, 2023 11:20:00 AM
DCCI marked a new era for Malaysia's datacentre & cloud ecosystem  
June 2, 2023 10:10 HKT/SGT
Graid Technology Awarded Prestigious COMPUTEX 2023 Best Choice Golden Award for SupremeRAID Revolutionary GPU-based RAID Controller  
June 2, 2023 07:00 HKT/SGT
Asensus Shares First Quarter Results and Future Plans  
June 1, 2023 21:40 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2023 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: